Revolution Medicines, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Revolution Medicines, Inc. (RVMD) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 74.16 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 74.16M shares, a 5.31% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 73.82M shares, a 11.17% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 73.54M shares, a 13.32% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 73.40M shares, a 24.93% increase year-over-year.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 72.81M shares, a 32.68% increase from fiscal 2020.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 54.87M shares, a 1879.17% increase from fiscal 2019.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.77M shares, a 20.61% increase from fiscal 2018.
- Revolution Medicines, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 2.30M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 74.16M shares 10-Q · filed 2022-05-09 | 73.99M shares derived: average of 2 quarters · filed 2022-05-09 | 73.84M shares derived: average of 3 quarters · filed 2022-05-09 | 73.73M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 73.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 73.68M shares derived: average of 2 quarters · filed 2022-02-28 | 73.59M shares derived: average of 3 quarters · filed 2022-02-28 | 72.81M shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 73.54M shares 10-Q · filed 2021-11-10 | 73.47M shares derived: average of 2 quarters · filed 2021-11-10 | 72.47M shares 10-Q · filed 2021-11-10 | 70.94M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-06-30 | 73.40M shares 10-Q · filed 2021-08-11 | 71.92M shares 10-Q · filed 2021-08-11 | 70.07M shares derived: average of 3 quarters · filed 2022-05-09 | 68.78M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-03-31 | 70.42M shares 10-Q · filed 2022-05-09 | 68.41M shares derived: average of 2 quarters · filed 2022-05-09 | 67.24M shares derived: average of 3 quarters · filed 2022-05-09 | 65.12M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 66.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 65.65M shares derived: average of 2 quarters · filed 2022-02-28 | 63.35M shares derived: average of 3 quarters · filed 2022-02-28 | 54.87M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 64.89M shares 10-Q · filed 2021-11-10 | 61.82M shares derived: average of 2 quarters · filed 2021-11-10 | 51.03M shares 10-Q · filed 2021-11-10 | 38.97M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | 58.75M shares 10-Q · filed 2021-08-11 | 44.03M shares 10-Q · filed 2021-08-11 | 30.32M shares derived: average of 3 quarters · filed 2022-02-28 | 23.44M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | 29.30M shares 10-Q · filed 2021-05-10 | 16.11M shares derived: average of 2 quarters · filed 2022-02-28 | 11.67M shares derived: average of 3 quarters · filed 2022-02-28 | 9.44M shares derived: average of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | 2.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 2.86M shares derived: average of 2 quarters · filed 2022-02-28 | 2.81M shares derived: average of 3 quarters · filed 2022-02-28 | 2.77M shares 10-K · filed 2022-02-28 |
| 2019-09-30 | 2.81M shares 10-Q · filed 2020-11-12 | 2.76M shares derived: average of 2 quarters · filed 2020-11-12 | 2.72M shares 10-Q · filed 2020-11-12 | |
| 2019-06-30 | 2.72M shares 10-Q · filed 2020-08-10 | 2.68M shares 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | 2.64M shares 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | 2.30M shares 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |